8-K

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                  _____________

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported)     October 30, 2002


                                ICU MEDICAL, INC.

             (Exact name of registrant as specified in its charter)

          DELAWARE                        0-19974                 33-0022692
          --------                        -------                 ----------
(State or other jurisdiction     (Commission File Number)     (I.R.S. Employer
      of incorporation)                                      Identification No.)


951 Calle Amanecer, San Clemente, California                        92673
- --------------------------------------------                        -----
  (Address of principal executive offices)                        (Zip Code)


                                 (949) 366-2183
                                 --------------
               Registrant's telephone number, including area code


                                       N/A
                                       ---
          (Former name or former address, if changed since last report)



ITEM 5.  OTHER EVENTS.

         On October 30, 2002, ICU Medical, Inc. (the "Company") signed
agreements to acquire the following securities of Bio-Plexus, Inc. from ComVest
Venture Partners, L.P. and other investors:

         9,695,961 shares of common stock, representing 84% of the common stock
outstanding;

         1,294,785 warrants to purchase Common Stock at an exercise price of
$2.28 per share;

         $2,499,999, 7% Senior Subordinated Non-convertible Promissory Notes.

         The aggregate consideration to be paid for the common stock and
warrants is $6,404,667 and for the notes is $2,499,999.

         The Company intends to acquire the remaining minority interest in the
near future at the same price per share.

Item 7.  FINANCIAL STATEMENTS AND EXHIBITS

(c)      Exhibits

99. Press Release dated October 30, 2002.



                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  October 31, 2002

                                ICU MEDICAL, INC.



                                /s/ Francis J. O'Brien
                                ------------------------
                                Francis J. O'Brien
                                Secretary, Treasurer and
                                Chief Financial Officer

EX-99

                                                                      Exhibit 99


[ICU MEDICAL, INC. LOGO]

          ICU MEDICAL, INC. AGREES TO BUY INTEREST IN BIO-PLEXUS, INC.

         OCTOBER 30, 2002, SAN CLEMENTE, CALIFORNIA -- ICU Medical, Inc.
(NASDAQ/NMS:ICUI), the San Clemente based maker of safe medical connectors and
custom intravenous systems, today announced that it has agreed to acquire 84% of
the Common stock of Bio-Plexus, Inc. (OTC BB:BPXS) from ComVest Venture
Partners, L.P. and other investors for cash at a price of $0.66 per share. ICU
Medical will also acquire $2.5 million of notes payable by Bio-Plexus. The
parties intend to close the transaction within several days. ICU Medical intends
to engage in one or more transactions to acquire the remaining minority interest
at the same price per share in the near future.

         ComVest Venture Partners, L.P. is a private investment fund
specializing in healthcare and technology ventures.


         Bio-Plexus's principal products are blood collection needles under the
PUNCTURE-GUARD(R) name, which are designed to eliminate exposure to sharp,
contaminated needles.




CONTACT:      Francis J. O'Brien
              Chief Financial Officer
              ICU Medical, Inc.
              (949) 366-2183